Ichinose Y - Search Results

1

Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinum.

Seto T, Yamanaka T, Nakano M, Ota M, Maruyama R, Okamoto T, Wataya H, Uematsu K, Seki N, Eguchi K, Semba H, Ichinose Y. Seto T, et al. Among authors: ichinose y. J Thorac Oncol. 2008 Jun;3(6):637-42. doi: 10.1097/JTO.0b013e318174e070. J Thorac Oncol. 2008. PMID: 18520804 Free article. Clinical Trial.

2

Uracil/tegafur plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a multi-institutional phase II trial.

Ichinose Y, Nakai Y, Kudoh S, Semba H, Yoshida S, Nukiwa T, Yamamoto H, Yamane Y, Niitani H. Ichinose Y, et al. Clin Cancer Res. 2004 Jul 1;10(13):4369-73. doi: 10.1158/1078-0432.CCR-04-0143. Clin Cancer Res. 2004. PMID: 15240524 Clinical Trial.

3

Clinical patterns and treatment outcome of elderly patients in clinical stage IB/II non-small cell lung cancer.

Okamoto T, Maruyama R, Shoji F, Ikeda J, Miyamoto T, Nakamura T, Asoh H, Ichinose Y. Okamoto T, et al. Among authors: ichinose y. J Surg Oncol. 2004 Sep 1;87(3):134-8. doi: 10.1002/jso.20095. J Surg Oncol. 2004. PMID: 15334641

4

Long-term survivors in stage IV non-small cell lung cancer.

Okamoto T, Maruyama R, Shoji F, Asoh H, Ikeda J, Miyamoto T, Nakamura T, Miyake T, Ichinose Y. Okamoto T, et al. Among authors: ichinose y. Lung Cancer. 2005 Jan;47(1):85-91. doi: 10.1016/j.lungcan.2004.06.006. Lung Cancer. 2005. PMID: 15603858

5

Serum carcinoembryonic antigen as a predictive marker for sensitivity to gefitinib in advanced non-small cell lung cancer.

Okamoto T, Nakamura T, Ikeda J, Maruyama R, Shoji F, Miyake T, Wataya H, Ichinose Y. Okamoto T, et al. Among authors: ichinose y. Eur J Cancer. 2005 Jun;41(9):1286-90. doi: 10.1016/j.ejca.2005.03.011. Eur J Cancer. 2005. PMID: 15939264

6

[Postoperative adjuvant chemotherapy for non-small cell lung cancer].

Okamoto T, Ichinose Y. Okamoto T, et al. Among authors: ichinose y. Gan To Kagaku Ryoho. 2005 Jun;32(6):765-9. Gan To Kagaku Ryoho. 2005. PMID: 15984513 Review. Japanese.

7

Triplet chemotherapy with cisplatin, gemcitabine and vinorelbine for malignant pleural mesothelioma.

Maruyama R, Shoji F, Okamoto T, Miyamoto T, Miyake T, Nakamura T, Ikeda J, Aoki Y, Wataya H, Asoh H, Ichinose Y. Maruyama R, et al. Among authors: ichinose y. Jpn J Clin Oncol. 2005 Aug;35(8):433-8. doi: 10.1093/jjco/hyi127. Epub 2005 Jul 8. Jpn J Clin Oncol. 2005. PMID: 16006571

8

Phase I study of amrubicin hydrochloride and cisplatin in patients previously treated for advanced non-small cell lung cancer.

Ikeda J, Maruyama R, Okamoto T, Shoji F, Wataya H, Ichinose Y. Ikeda J, et al. Among authors: ichinose y. Jpn J Clin Oncol. 2006 Jan;36(1):12-6. doi: 10.1093/jjco/hyi217. Epub 2006 Jan 17. Jpn J Clin Oncol. 2006. PMID: 16418184 Clinical Trial.

9

[A case of adenocarcinoma of the lung significantly responding to TS-1 plus cisplatin combination chemotherapy].

Wataya H, Asou H, Maruyama R, Okamoto T, Suemitsu R, Ichinose Y. Wataya H, et al. Among authors: ichinose y. Gan To Kagaku Ryoho. 2006 Apr;33(4):501-3. Gan To Kagaku Ryoho. 2006. PMID: 16612161 Clinical Trial. Japanese.

10

Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.

Seto T, Higashiyama M, Funai H, Imamura F, Uematsu K, Seki N, Eguchi K, Yamanaka T, Ichinose Y. Seto T, et al. Among authors: ichinose y. Lung Cancer. 2006 Jul;53(1):91-6. doi: 10.1016/j.lungcan.2006.02.009. Epub 2006 May 11. Lung Cancer. 2006. PMID: 16697074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

696 results

Search Page

Filters